Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Cancer Stage III”

2,290 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,290 results

Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Not applicableStudy completedNCT03949270
What this trial is testing

Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer

Who this might be right for
Breast CancerAdherence, MedicationSide Effect
Yale University 400
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Early research (Phase 1)Ended earlyNCT01032122
What this trial is testing

Rituximab in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Medical University of Vienna 9
Very early researchLooking for participantsNCT04741997
What this trial is testing

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVBRAF V600 Mutation
H. Lee Moffitt Cancer Center and Research Institute 50
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT01407770
What this trial is testing

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Who this might be right for
Breast CancerCognitive Ability, GeneralFatigue+4 more
Wake Forest University Health Sciences 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT06190951
What this trial is testing

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 151
Large-scale testing (Phase 3)Study completedNCT01359956
What this trial is testing

Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma

Who this might be right for
Malignant MelanomaRecurrent Melanoma
National Cancer Institute, Naples 269
Large-scale testing (Phase 3)Study completedNCT00014222
What this trial is testing

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 2,104
Large-scale testing (Phase 3)Study completedNCT01864746
What this trial is testing

Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery

Who this might be right for
Breast CancerHormonreceptor PositiveHer2-normal+2 more
GBG Forschungs GmbH 1,250
Testing effectiveness (Phase 2)Study completedNCT00052351
What this trial is testing

Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT05767879
What this trial is testing

(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma

Who this might be right for
Melanoma Stage IIIIn-Transit Metastasis of Cutaneous Melanoma
Leiden University Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT01431196
What this trial is testing

Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer

Who this might be right for
Stage II Breast CancerStage III Breast Cancer
Clinica Universidad de Navarra, Universidad de Navarra 29
Not applicableActive Not RecruitingNCT01942603
What this trial is testing

Minimal SN Tumor Burden

Who this might be right for
Cutaneous Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 296
Early research (Phase 1)Study completedNCT00217542
What this trial is testing

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage III Melanoma+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT02014441
What this trial is testing

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

Who this might be right for
Melanoma
Amgen 61
Large-scale testing (Phase 3)Study completedNCT02555657
What this trial is testing

Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119)

Who this might be right for
Metastatic Triple Negative Breast Cancer
Merck Sharp & Dohme LLC 622
Testing effectiveness (Phase 2)Study completedNCT06152367
What this trial is testing

Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients

Who this might be right for
Stage III Malignant Melanoma of Skin AJCC V6Stage IV Malignant Melanoma of Skin
University of Chile 90
Load More Results